Skip to Main Content

Paper Details

Potently neutralizing and protective human antibodies against SARS-CoV-2.
Nature
786
2020
Author NameAffiliation
Pavlo GilchukVanderbilt University Medical Center
Rita E ChenWashington University School of Medicine
Rita E ChenWashington University School of Medicine
Alexandra Sch??ferUniversity of North Carolina at Chapel Hill
Jens MeilerVanderbilt University
Jens MeilerLeipzig University Medical School, Institute for Drug Discovery
Michael J HoltzmanWashington University School of Medicine
Michael J HoltzmanWashington University School of Medicine
Dan H BarouchCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School
Lisa E GralinskiUniversity of North Carolina at Chapel Hill
Lisa E GralinskiUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
Larissa B ThackrayWashington University School of Medicine
Michael S DiamondWashington University School of Medicine
Michael S DiamondWashington University School of Medicine
Michael S DiamondWashington University School of Medicine
Michael S DiamondAndrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine
Robert H CarnahanVanderbilt University Medical Center
Robert H CarnahanVanderbilt University Medical Center
James E CroweVanderbilt University Medical Center
James E CroweVanderbilt University Medical Center
James E CroweVanderbilt University Medical Center
  • 1 - 23

Datasets

Release 1.2